Page last updated: 2024-11-05

polyethylene glycol 300

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Polyethylene glycol 300 (PEG 300) is a synthetic polymer with a molecular weight of approximately 300 g/mol. It is a clear, colorless, viscous liquid that is soluble in water and many organic solvents. PEG 300 is produced by the polymerization of ethylene oxide. It is widely used in various industrial and pharmaceutical applications due to its unique properties, including its non-toxic nature, biocompatibility, and ability to enhance the solubility and bioavailability of drugs. It is also used as a solvent, plasticizer, and lubricant. PEG 300's safety and versatility have led to extensive research and development in diverse fields like pharmaceuticals, cosmetics, and food additives. Its importance lies in its ability to improve drug delivery, enhance product stability, and contribute to various manufacturing processes. '

Cross-References

ID SourceID
PubMed CID17472
CHEMBL ID1235082
CHEBI ID49793
SCHEMBL ID38159
MeSH IDM0017179

Synonyms (53)

Synonym
CHEMBL1235082
AKOS015839803
ethanol,2'-[oxybis(oxy-2,1-ethanediyloxy-2,1-ethanediyloxy)]bis-
hexagol
nsc-201209
3,9,12,15-pentaoxaheptadecane-1,17-diol
2615-15-8
nsc201209
ethanol,2'-[oxybis(ethyleneoxyethyleneoxy)]di-
wln: q2/o2/ 5q
hexaoxyethylene glycol
3,6,9,12,15-pentaoxaheptadecane-1,17-diol
6529-43-7
ai3-01457
einecs 220-045-1
brn 1638281
ethanol, 2,2'-(oxybis(ethyleneoxyethyleneoxy))di-
peg-6
nsc 201209
hexaethylene glycol
p6g ,
NCGC00159371-02
NCGC00159371-03
hexaethylene glycol, 97%
CHEBI:49793 ,
2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol
4-01-00-02406 (beilstein handbook reference)
trans-2-o-tolylcyclopropanecarboxylic acid
FT-0602028
BP-21034
BP-21475
hexaethyleneglycol
SCHEMBL38159
H1432
DTXSID2058629
hexa[ethylene glycol]
ethanol, 2,2'-(oxybis(oxy-2,1-ethanediyloxy-2,1-ethanediyloxy))bis-
mfcd00002877
c12h26o7
hexaethylene glycol, purum, >=95.0% (gc)
ho-peg6-oh
J-016283
SY024148
2-[2-(2-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethoxy}-ethoxy)-ethoxy]-ethanol
Q27104720
AS-19157
AMY19025
A877353
CS-0115001
HY-141230
EN300-226100
oh-peg6-oh
2,2'-[oxybis(ethyleneoxyethyleneoxy)]bisethanol
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
poly(ethylene glycol)A polymer composed of repeating ethyleneoxy units.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency5.01190.003245.467312,589.2998AID2517
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.78)18.7374
1990's4 (11.11)18.2507
2000's12 (33.33)29.6817
2010's17 (47.22)24.3611
2020's2 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.75 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index5.25 (4.65)
Search Engine Demand Index80.56 (26.88)
Search Engine Supply Index2.99 (0.95)

This Compound (39.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]